Trends in the incidence, demographics, and outcomes of end-stage renal disease due to lupus nephritis in the US from 1995 to 2006.
Trends in the incidence, demographics, and outcomes of end-stage renal disease due to lupus nephritis in the US from 1995 to 2006.
复制标题
DOI:
10.1002/art.30293
复制
发表时间:
2011-06
影响因子:
--
通讯作者:
Winkelmayer, Wolfgang C.
中科院分区:
文献类型:
--
作者:
Costenbader, Karen H.;Desai, Amrita;Alarcon, Graciela S.;Hiraki, Linda T.;Shaykevich, Tamara;Brookhart, M. Alan;Massarotti, Elena;Lu, Bing;Solomon, Daniel H.;Winkelmayer, Wolfgang C.
It is unknown whether recent advances lupus nephritis (LN) treatment have led to changes in the incidence of end-stage renal disease (ESRD) secondary to LN, or in the characteristics, therapies, and outcomes of patients with LN ESRD. Patients with incident LN ESRD (1995–2006) were identified in the US Renal Datasystem. Trends in sociodemographic and clinical characteristics were assessed. We tested for temporal changes in standardized incidence rates (SIRs) for sociodemographic groups using Poisson regression. Changes in rates of waitlisting for kidney transplant, kidney transplantation, and all-cause mortality were examined using crude and adjusted time-to-event analyses. 12,344 incident cases of LN ESRD were identified. Mean age at ESRD onset was 41 years; 81.6% were female and 49.5% African American. SIRs for LN ESRD among those ages 5–39, African Americans, and in the US Southeast increased significantly from 1995–2006. Increases in body mass index and the prevalence of both diabetes and hypertension were detected. Mean serum hemoglobin at ESRD onset increased, while that of serum creatinine decreased over time. More patients used hemodialysis and fewer peritoneal dialysis. There was a slight increase in pre-emptive kidney transplantation at ESRD onset, but kidney transplantation rates within the first three years of ESRD declined. Mortality did not change over 12 years of study. The characteristics of LN ESRD patients and their initial therapies have changed in recent years. While SIRs rose in younger patients, among African Americans and in the South, outcomes did not improve in over a decade of evaluation.
登录
查看更多内容
影响因子:
2.1
作者:
Tang, Hongying;Chelamcharla, Madhukar;Goldfarb-Rumyantzev, Alexander S.
通讯作者:
Goldfarb-Rumyantzev, Alexander S.
影响因子:
5.9
作者:
APPEL, GB;COHEN, DJ;ESTES, D
通讯作者:
ESTES, D
影响因子:
2.6
作者:
Ponticelli, C;Moroni, G
通讯作者:
Moroni, G
影响因子:
1.5
作者:
Danieli, MG;Palmieri, C;Danieli, G
通讯作者:
Danieli, G
影响因子:
2.6
作者:
Carreño, L;López-Longo, FJ;Lapointe, N
通讯作者:
Lapointe, N